Jack Nathan Medical Corp.
JNHMF
$0.00
$0.000.00%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 165.60K | 130.30K | 1.94M | 3.84M | 193.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 165.60K | 130.30K | 1.94M | 3.84M | 193.20K |
| Cost of Revenue | 171.80K | 163.70K | -253.30K | 705.00K | 248.50K |
| Gross Profit | -6.20K | -33.40K | 2.19M | 3.14M | -55.30K |
| SG&A Expenses | 312.20K | 253.90K | 1.90M | 3.84M | 485.90K |
| Depreciation & Amortization | 27.80K | 26.80K | -128.50K | 233.90K | 40.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 511.80K | 444.40K | 1.51M | 4.78M | 774.70K |
| Operating Income | -346.20K | -314.00K | 423.00K | -931.00K | -581.60K |
| Income Before Tax | -181.60K | -325.30K | 661.20K | -1.32M | -603.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -181.60K | -325.30K | 649.70K | -1.32M | -603.20K |
| Earnings from Discontinued Operations | 150.90K | -395.80K | 7.19M | -- | -184.50K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.70K | -721.10K | 7.84M | -1.32M | -787.70K |
| EBIT | -346.20K | -314.00K | 423.00K | -931.00K | -581.60K |
| EBITDA | -334.90K | -297.30K | 470.80K | -748.70K | -398.20K |
| EPS Basic | 0.00 | -0.01 | 0.09 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.09 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 87.10M | 87.10M | 87.10M | 87.10M | 84.73M |
| Average Diluted Shares Outstanding | 87.43M | 87.10M | 87.43M | 96.10M | 88.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |